Active substance
Mepivacaine
- SFDA 5
- US FDA 16
- Health Canada 7
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ISOCAINE 3 % CARTRIDGE | 3 % | Solution for injection · Dental use | 50 Cartridge | SAR 70.70 | Generic · Prescription | NOVOCOL | Valid |
| MEDICAINE 3% CARTRIDGE | 30 mg | Solution for injection in cartridge · Dental use | 50 Cartridge | SAR 94.60 | NCE · Prescription | LES LABORATOIRES MEDIS | Valid |
| SCANDICAINE 3% CARTRIDGE 1.8ML | 3 % | Solution · Dental use | 50 Cartridge | SAR 99.60 | NCE · Prescription | SEPTODENT | Valid |
| MEPECAINE 3% CARPULE | 3 % | Solution for injection in cartridge · Dental use | 50 Cartridge | SAR 50.40 | Generic · Prescription | ALEXANDRIA CO. | Withdrawn by regulatory authority · Not Marketed |
| MEPICATON 3% CARTRIDGES (1.8)ML | 3 % | Solution · Dental use | 50 Cartridge | SAR 68.90 | Generic · Prescription | WEIMER PHARMA | Withdrawn by regulatory authority · Not Marketed |
Indications — CHI Daman Drug Formulary
ANESTHESIA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| SCANDONEST PLAIN | 3% | injectable · injection | DEPROCO | Prescription | 10 Oct 1984 |
| POLOCAINE-MPF | 1% | injectable · injection | FRESENIUS KABI USA | Prescription | 1 Dec 1986 |
| POLOCAINE | 1% | injectable · injection | FRESENIUS KABI USA | Prescription | 1 Dec 1986 |
| POLOCAINE-MPF | 1.5% | injectable · injection | FRESENIUS KABI USA | Prescription | 1 Dec 1986 |
| POLOCAINE-MPF | 2% | injectable · injection | FRESENIUS KABI USA | Prescription | 1 Dec 1986 |
| POLOCAINE | 2% | injectable · injection | FRESENIUS KABI USA | Prescription | 1 Dec 1986 |
| CARBOCAINE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | EASTMAN KODAK | Discontinued | 6 Jan 1960 |
| CARBOCAINE | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | HOSPIRA | Discontinued | 17 May 1960 |
| ISOCAINE HYDROCHLORIDE | 3% | injectable · injection | SEPTODONT | Discontinued | 17 Oct 1972 |
| MEPIVACAINE HYDROCHLORIDE | 3% | injectable · injection | BELMORA LLC | Discontinued | 4 Dec 1973 |
| ARESTOCAINE HYDROCHLORIDE | 3% | injectable · injection | SOLVAY | Discontinued | 17 Dec 1975 |
| MEPIVACAINE HYDROCHLORIDE | 1% | injectable · injection | INTL MEDICATION SYS | Discontinued | 5 Oct 1982 |
| POLOCAINE | 3% | injectable · injection | DENTSPLY PHARM | Discontinued | 21 Aug 1984 |
| MEPIVACAINE HYDROCHLORIDE | 1% | injectable · injection | WATSON LABS | Discontinued | 20 Nov 1984 |
| MEPIVACAINE HYDROCHLORIDE | 2% | injectable · injection | WATSON LABS | Discontinued | 20 Nov 1984 |
| MEPIVACAINE HYDROCHLORIDE | 3% | injectable · injection | HOSPIRA INC | Discontinued | 28 Apr 2008 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| 3% POLOCAINE DENTAL | 02330733 | 30 MG / ML | LIQUID · BLOCK/INFILTRATION | DENTSPLY CANADA LIMITED |
| CARBOCAINE 1% | 02241999 | 10 MG / ML | SOLUTION · INTRACAUDAL; EPIDURAL | PFIZER CANADA ULC |
| CARBOCAINE 1% | 02242000 | 10 MG / ML | SOLUTION · BLOCK/INFILTRATION | PFIZER CANADA ULC |
| CARBOCAINE 2% | 02242001 | 20 MG / ML | SOLUTION · EPIDURAL; INTRACAUDAL | PFIZER CANADA ULC |
| CARBOCAINE 3% | 02474174 | 30 MG / ML | SOLUTION · BLOCK/INFILTRATION | SEPTODONT |
| ISOCAINE HCL INJ 3% | 00364304 | 30 MG / ML | SOLUTION · BLOCK/INFILTRATION | NOVOCOL PHARMACEUTICAL OF CANADA INC |
| SCANDONEST 3% PLAIN INJ | 00479934 | 30 MG / ML | SOLUTION · BLOCK/INFILTRATION | SEPTODONT |
Safety signals and safety-related labeling changes
- US FDA 21 Dec 2023 CARBOCAINE — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Mepivacaine
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.